I. INTRODUCTION
A war is raging; it is one that includes all members of society: the indigent, wealthy, young, old, and all flavors of race, nationality, and gender. It is the war on prescription medication. According to the Drug Enforcement Administration ("DEA"), six million Americans currently abuse a prescription drug, which is more than abusers of heroin, cocaine, hallucinogens, and inhalants combined. 2 1.85 million people are estimated to be dependent on or abusing schedule II controlled substances, also known as opioids. 3 In 2009, 1.2 million individuals were treated in an emergency department for conditions involving pharmaceutical drug use, which is a ninety-eight percent increase from 2004 . 4 This increase is especially startling considering that emergency room treatment involving illicit drugs has remained virtually unchanged over the same period. 5 In response, Federal and State governments have taken multiple steps to address this serious and growing problem. On September 25, 2010, the DEA held its first "National Indiana has a particularly concerning controlled substance abuse problem. In the most recent Substance Abuse and Mental Health Services Administration ("SAMHSA") report, Indiana ranked among the highest in the country for non-medical pain reliever use in all age groups except ages twelve through seventeen. 9 However, Indiana has also adopted measures to combat prescription drug abuse and diversion, including Indiana's controlled substance monitoring program ("INSPECT" program) created in 2006, 10 and the passage by the state legislature of the Prescription Drug Disposal Sites -House Bill 1121, 11 which would allow individuals to return unused medications to their pharmacy for proper disposal.
12 Also, in the past year the Office of the Indiana Attorney General has prosecuted numerous physicians who divert and improperly prescribe prescription drugs.
13
Prescription drug abuse has become a crisis nationally and in Indiana and more safeguards are needed. However, in developing additional safeguards by regulating access to prescription drugs, one must be careful not to unnecessarily restrict access from legitimate users. While prescription drugs are widely abused, they can also provide life altering relief from pain that cannot otherwise be treated. As a casualty in the war on prescription drug abuse, undertreated pain has quietly become a nationwide epidemic.
14 Many factors contribute to under- treated pain, but one important influence is physician concern about both law enforcement and regulatory scrutiny: physicians are reluctant to prescribe adequate amounts of controlled substances for pain because of the potential for investigation by the DEA and the state medical licensing board. 15 As a result, patients indirectly suffer from amped-up efforts to control prescription drug abuse by focusing on physician prescribing practices. Therefore, regulations placed on prescription drugs must consider all interests implicated and fashion a strategy that serves to address prescription drug abuse while allowing doctors to adequately treat the pain of their patients. This Note will argue that the Indiana Medical Licensing Board should pass guidelines for the use of controlled substances for the treatment of pain. Guidelines would address the ever-increasing concern over prescription drug abuse by creating a standard that would allow physicians to prescribe proper amounts of controlled substances for pain treatment without fear of investigation. In addition, guidelines would provide a method for the Office of the Indiana Attorney General to assess and take appropriate action against physicians who use medicine as a pretext for diversion and ultimately are not prescribing for legitimate medical purposes and give the Indiana Medical Licensing Board an evaluation tool to properly scrutinize physician prescribing practices. This Note will consider the interests implicated by the adoption of guidelines for controlled substances in the context of pain treatment including patients, physicians, the Office of the Indiana Attorney General, the Indiana Medical Licensing Board, and Indiana citizens generally. Further, this Note will consider several disciplinary actions and criminal convictions of Indiana physicians who have been disciplined for their prescribing practices and compare Indiana law and regulations with the efforts of Michigan in the area of pain management using controlled substances. This Note concludes that guidelines adopted by the Indiana Medical Licensing Board will serve all interests involved and will ameliorate prescription drug abuse and diversion while alleviating undertreated pain and physician fear in Indiana. II. BACKGROUND
In Indiana, there are two agencies that are involved in regulating the professional practice of physicians. The Office of the Indiana Attorney General ("AG") is the investigative and prosecutorial arm, 16 and the Indiana Medical Licensing Board ("Board") is the entity that licenses and disciplines physician practice. 17 Any action conducted by these agencies only relates to the physician's license and ability to legally practice medicine in Indiana. 18 No criminal penalties are imposed, although a finding of unprofessional conduct allows for discipline on the physician's license. 19 The process begins when the AG receives allegations of improper physician conduct, which can come from a variety of sources, including patient complaints, other state disciplinary committees, media outlets, and the Board itself.
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After receiving this information, the AG conducts an investigation of the alleged conduct, including a response to the allegations by the physician in question. 21 After a thorough review of the information available, the AG makes a recommendation of the action to be taken and submits it to a member of the Board for their comments and impressions. 22 Based on the Board member's comments and in-house attorney recommendations, the AG will then decide whether to file a formal administrative complaint against the physician or close the matter altogether. 23 In the event that the AG decides to take action against the physician's license, they will file a formal administrative complaint with the Board. 24 The complaint will allege that the physician has committed a licensing violation under Indiana Code ("IC") section 25-1-9-4, 25 which is commonly referred to as the Licensing Charging Statute. 26 The physician will then either decide to settle with the AG, subject to the Board's approval, or defend the allegations in an administrative hearing before the Board. 27 The AG serves as the prosecution in the hearings.
28
The hearing takes place before the Board, which is comprised of up to seven members appointed by the Governor. 29 Six Board members are physicians from all over Indiana, and at least one physician must be a doctor of osteopathy while the other five must be doctors of medicine. 30 The last member is a consumer member that can be any citizen of Indiana and serves as a representative of all Indiana consumers. 31 The Board is charged with regulating physician practice in Indiana and protecting consumers from fraud and abuse by licensed physicians. 32 The Board primarily consists of physicians because it is believed that they are in the best position to evaluate medical practice. 33 As such, the Board promulgates rules for the practice of medicine, approves physicians for licensure, and disciplines physicians who violate Indiana law and the professional standards for the practice of medicine set by the Board. 34 The Board may discipline the physician's license by issuing a letter of public reprimand; by taking action on the physician's license, including revocation, suspension, or probation; by imposing fines up to $1,000 for each violation; or by a combination of the penalties listed.
35
In order to impose disciplinary action on a physician's license, the Board must find that the physician violated one of the thirteen provisions found under IC 25-1-9-4 ("Charging Statute"). 36 Such provisions prohibit physician-patient sexual relations, prescription drug diversion, the use of material deception to obtain a license to practice, failure to keep abreast of current professional theory or practice, and others. 37 Moreover, the Board is authorized to promulgate additional rules, 38 a violation of which would constitute varying violations of the charging statute. 39 These rules are tai- . This statute recognizes two other specific instances in which the Board has authority impose discipline, which are Indiana Code section 25-1-9-6.8, "Practitioner guidelines before prescribing stimulant medication for a child for treatment of certain disorders," and Indiana Code section 25-1-9-6.9, "Failing to provide or providing false information to agency." However, these statutes are rarely invoked and the discipline in the scope of this Note is covered under the charging statute.
37. IND. CODE § 25-1-9-4 (2010 When statutes, regulations, or policy statements are adopted, passed, and implemented, unintended parties may be affected for good or ill. Especially in the area of health law, where life-saving work is being performed, a careful examination of all implicated parties is necessary to properly balance the interests and devise an appropriate strategy for accomplishing the desired goal. For the purposes of this Note, the interested parties are patients, prescribing physicians, the AG, the Board, and the general public. Patients receive pain treatment through appropriate physician prescribing; the physicians prescribe and earn a living through their practice; the AG is empowered by the state to protect the health and welfare of Indiana citizens by bringing complaints against licensed Indiana physicians; the Board is empowered to protect the health and welfare of Indiana citizens by disciplining the license of Indiana physicians; and, the Indiana public has an interest in protection from prescription drug abuse.
A. The Patient
In the context of using controlled substances for pain treatment, the patient's interest is receiving safe and effective pain treatment and relief from suffering. 45 Patients are the ones who are experiencing pain and are in need of help. Generally, three types of pain are recognized: acute, chronic 41 . IND. CODE § 25-1-9-4(a)(4)(B) (2010). 42. 844 IND. ADMIN. CODE 5-3-3 (2010). 43. Edwards, Findings of Fact and Order, supra note 13. 44. For example, Indiana Code section 25-1-9-4(a)(8)(A) which states "a practitioner has diverted: a legend drug (as defined in IC 16-18-2-199)" is a licensing violation subject to discipline by the Board under Indiana Code section 25-1-9-9, but would also be a violation of Indiana Code section 35-48-4-2, "Dealing in a schedule I, II, or III controlled substance," and subject to criminal prosecution as a Class B felony.
45. Rich, supra note 14, at 31 ("The suffering at issue is that of the patient with whom he or she has entered into a professional relationship.").
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[Vol. 9:2 non-cancer pain, and chronic cancer related pain. 46 This Note will address chronic non-cancer pain because such pain is outside the scope of palliative care and is frequently targeted by guidelines and provisions to prevent abuse and addiction. 47 "Chronic non-cancer pain is associated with significant economic, societal, and health impact." 48 On the economic front, the cost of uncontrolled non-cancer chronic pain is extreme. In 1998 it was estimated that total expenditures for back pain was $90.7 billion and, on average, people with back pain cost health care insurance providers sixty percent more than those without back pain. 49 "It was estimated [in 1998 ] that the cost of health care for patients with chronic pain might exceed the combined cost of treating patients with coronary artery disease, cancer, and AIDS."
50
From a societal perspective, undertreated pain directly impacts a patient's quality of life. 51 It is not easy living with unremitted moderate to severe pain, and, in certain cases, excessive pain can lead to depression and even suicide. 52 Undertreated pain has been equated and compared to inflicting pain on the suffering patient and, as such, has implicated ethical and judicial/licensing liability concerns. It is argued that "[h]ealth care providers also should not inflict unnecessary pain and suffering . . . . [A]llowing a patient to experience unnecessary pain and suffering of any form is substandard and unethical medical practice regardless of the nature of the patient's condition or the goals of medical intervention."
53
In light of the fact that unrelieved pain is an undue burden on patients, controlled substances in the morphine class known as opioids can be used as safe and effective ways to treat patient pain, especially when the pain is severe. 54 55 Therefore, any restriction or regulation on pain patients' access to opioids impacts the patients' ability to receive powerful solutions to their chronic and potentially debilitating pain.
B. The Prescribing Physician
The physicians implicated in this Note are those who prescribe controlled substances to treat their patients' pain. These physicians have a twofold interest: their duty to their patients and their interest in perpetuating their practice in medicine.
Duty to Treat Patient Pain
The physician's first interest is in maintaining his duty to properly treat his patients and, in cases of pain management, adequately treating pain.
56
When conducting an inquiry into the duties of a physician, the first step (and sometimes last resort) is to consult the Hippocratic Oath. However, . . . the fact that the Oath makes no specific reference to the relief of suffering should not be dispositive of the issue of the physician's duty in that regard.
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Philosopher Rem Edwards argues that "there is a broadly based humanistic ethics which applies to the domain of medical care which gives patients a strong prima facie right to freedom from unnecessary pain." 58 Further, the World Health Organization ("WHO") has recognized pain treatment as a basic human right and has determined that pain treatment is one of the most underestimated health care problems in the world. 59 It is argued that not relieving pain is almost akin to willfully inflicting it, and "[t]he willful infliction of pain is torture, which is foreclosed to the gov- While the issue of a patient's right to be free from pain is an ethical duty imposed on physicians in Indiana, the Oregon medical board has disciplined a physician for under-treated pain and a California jury awarded $1.5 million to the family of a man whose physician failed to provide proper amounts of pain medication before he died of cancer.
61 While there is concern that patients can become addicted to powerful opioids prescribed for pain relief, 62 especially when a patient has a history of substance abuse, some states have decided that such concerns are no excuse to allow patients to suffer. Whether imposed ethically or as a standard of practice, physicians have a duty to adequately address the pain of their patients or at least refer patients for such treatment. 
Interest in Perpetuating Practice in Medicine
The physician not only has an interest in relieving his patient's pain on legal and moral grounds, but also has a corresponding interest in maintaining his livelihood. Discipline for inappropriate prescribing can lead to the revocation of the physician's license or criminal penalties, thus ending the physician's ability to practice medicine and potentially earn a living. 64 The physician must preserve his ability to work. He has a duty to his patients, but maybe a greater one of self-preservation and the continued validity of his license.
Because of the physician's interest to maintain an unrestricted license, restrictions or lack thereof on opioid prescribing is of major concern to prescribing physicians who are attempting to treat patient pain. Considering the war on prescription drug abuse, physicians are often hesitant to aggressively treat patient pain with opioid use out of anticipation that such practices will draw investigation by state and federal agencies. 63. Rich, supra note 14, at 34-35 (2000) ("American doctors regularly refuse to prescribe effective doses of narcotic painkillers to dying patients on the grounds that the patients might become addicted. The treatment of cancer pain, clearly, is still not based solely on scientific fact but draws on ignorance, fear, prejudice, and on an invisible, unacknowledged moral code expressing half-baked notions about the evil of drugs and the duty to bear affliction.").
64 In many cases, physicians claim that "bad laws" in the regulatory and legislative system force them to provide futile or poor care because they are more concerned with following the law than adequately treating their patients. 67 The concern here is that unclear or nonexistent law deters physicians from providing proper treatment for their patient's pain because physicians are either scared of government investigation or concerned about following the letter of the law, all to the detriment of the patient. Numerous studies have connected fear of regulatory scrutiny and ambiguous standards directly to incomplete pain treatment. 68 In a 1991 survey of physicians at the American Pain Society, forty percent of the physicians reported that fear of regulatory scrutiny, and not medical considerations, caused them to prescribe fewer opioids for pain treatment. 69 In a more startling 1993 California survey, sixty-nine percent of physicians stated they felt pain treatment was more conservative because of fear of government investigation, and one-third actually believed their patients were suffering from untreated pain. 70 In Indiana, there are no statutes, regulations, or standards of practice specifically tailored to address the use of controlled substances for pain treatment. Indiana's "bad law" is the lack of standards by which physicians are evaluated, thus directly contributing to physician fear of regulatory scrutiny by promoting ambiguity about the practice of pain management and indirectly preventing Indiana citizens from receiving proper pain treatopioid analgesics, even for the relief of severe pain which is unresponsive to other available pain management strategies. While the phenomenon of opiophobia is not unique to American culture, the openly declared war on drugs by American politicians and bureaucrats has produced a particularly virulent form of it in this country"); see also 
C. The Office of the Indiana Attorney General
As the AG investigates and prosecutes physicians who commit licensing violations, any new or additional regulation will affect that responsibility, thus impacting its ability to protect Indiana citizens. In the context of pain management, there are currently no regulations or standards of practice promulgated by the Board, therefore requiring the AG to seek general evidence that a physician's prescribing practice is harmful to the public. 73 When prosecuting physicians for prescribing practices under the charging statute, the AG can prosecute for "failure to keep abreast of current professional theory or practice," 74 diverting a controlled substance, 75 or "except as otherwise provided by law, has knowingly prescribed, sold, or administered any drug classified as a narcotic, addicting, or dangerous drug to a habitue or addict."
76 IC 25-1-9-4(a)(4)(B) ("Catch All statute"), which requires physicians to adhere to current professional theory and practice, is essentially the "Catch All" provision used to show that physicians have used substandard care in their practice. However, because of the general language used, the Catch All statute must be supplemented by some other source defining the actual conduct that is not professional theory or practice. Generally, violations of the provisions in 844 IAC 5, which contains the Standards of Professional Conduct and Competent Practice of Medicine adopted by the Board, or other Indiana medical statutes are used to invoke a violation of the Catch All statute. However, neither 844 IAC 5 nor any other Indiana provision addresses prescribing practices for pain treatment, and the AG is left to resort to organizational standards, common knowledge, or expert testimony. 77 In 2010, the AG successfully prosecuted several high profile cases involving prescribing practices, including revocations and fines against the 71. This Note recognizes that there are multiple factors contributing to physicians not adequately treating pain, but the burden is on the Board to take steps to get patients relief and fear of regulatory scrutiny is something they can directly address. See FED'N. OF 81 In each of these cases, it was clear the physician had prescribed for purposes other than those supported by legitimate medical reasons or in direct violation of a specific statute or regulation, thus invoking the Catch All statute and posing little difficulty for the AG to secure the discipline on their licenses. Under the current statutory format, the AG's interest in protecting Indiana citizens is only served when physicians violate the law in obvious and flagrant ways. However, the interest is not met when physicians keep some form of medical chart, do not prescribe over the Internet, or do not prescribe tens of thousands of opioids every month. In more tempered cases where physicians are careless or purposely prescribe for non-medical reasons, the AG lacks adequate tools with which to prosecute. If a physician is purposely over-prescribing, but maintains semi-proper charts and uses medicine or pain management as a pretext for diversion, the AG can do little under the current statutory scheme. Further, where a physician is careless or too trusting of his patients, the AG has a tremendous burden to show the physician has failed to keep abreast of current theory or practice, especially in an area where addicted patients are unlikely to report such practices. That is because the AG has no standard of practice to support a charge where the physician has ad hoc charts. In such instances, the AG can file a complaint and hope the physician will settle, but, while that might succeed in the latter case, it is unlikely when the physician uses medicine as a pretext for diversion. While the AG has statutory and regulatory backing to prosecute obnoxious cases and specific violations, those whose prescribing practices fall 78 on the borderline pose a much more difficult, if not impossible, challenge.
D. The Indiana Medical Licensing Board
When the AG prosecutes unlawful physician behavior, the Board is the judge, jury, and rule maker. It presides over cases filed by the AG against licensed physicians and determines discipline with an interest and duty to protect the health and welfare of Indiana citizens. 82 That interest is more pronounced considering the war on prescription drug abuse, and the fact that " cialists, and because they are the governor's appointees for finite terms subject to reappointment, they are subject to pressure from the legislature and the public to protect Indiana from unlawful physician practices. 88 This pressure is heightened by the fact that Indiana is experiencing a crisis in prescription drug abuse and the Board, unlike the AG, has the authority and arguably the duty to have appropriate standards by which physicians prescribe opioids. Because there are no officially adopted standards of practice when prescribing controlled substances for pain, the Board is left to look to other sources to determine whether the physician practice is proper.
IV. THE GUIDELINE SOLUTION
After review of the interests implicated, it is evident that steps need to be taken to address patient pain treatment, physician prescribing practices, and concern about regulatory scrutiny. In addition, the AG's ability to prosecute and the Board's ability to evaluate physicians' prescribing practices should be examined. The solution is to implement guidelines that clearly establish a standard of practice for physicians who are prescribing medication to treat pain, but in doing so, retain the flexibility to adjust with changes in acceptable medical practices while providing an enforcement mechanism to hold physicians accountable.
A. The Model Policy
In 1997, the Federation of State Medical Boards ("FSMB") developed guidelines for the use of controlled substances for the treatment of pain.
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The guidelines were established in an effort to encourage state medical boards to have a consistent approach to pain treatment when dealing with controlled substances and to provide a standard that would help ensure proper pain treatment. 90 Since its initial creation, the guidelines were revised in 2004 and have been titled "Model Policy for the Use of Controlled Substances for the Treatment of Pain" ("Model Policy"). 91 This document has been widely distributed and has been endorsed by the American Academy of Pain Medicine, the DEA, the American Pain Society, the National Association of State Controlled Substances Authorities, and the National Association of Attorneys General. 92 The Model Policy is comprised of 93 The Preamble states the policy considerations for the Model Policy; the Guidelines reflect the actual actions physicians should take in treating patients with opioids; and, definitions simply define the medical terms used in the document. 94 In addition, pain medicine specialist Dr. Scott Fishman has written a guide that fleshes out the Model Policy and explains how to implement it in daily medical practice. 95 The purpose of the policy is to encourage proper pain treatment in a time when undertreated pain is becoming a serious problem by outlining practices that are in compliance with federal and state law. 96 The Model Policy is designed to communicate certain messages to licensees: that the state medical board views pain management to be important and integral to the practice of medicine; that opioid analgesics may be necessary for the relief of pain; that the use of opioids for other than legitimate medical purposes poses a threat to the individual and society; that physicians have a responsibility to minimize the potential for the abuse and diversion of controlled substances; and that physicians will not be sanctioned solely for prescribing opioid analgesics for legitimate medical purposes. This policy is not meant to constrain or dictate medical decision-making. 97 Those messages are shared by each state medical boards that have adopted the Model Policy or some variation. Arguably, the Board has a similar attitude. However, without something published or recorded, such sentiment likely has little meaning or force with the physician community. Throughout the United States, forty-nine of fifty-one jurisdictions, including Washington D.C., have adopted some standard for the use of controlled substances for the treatment of pain through legislation, regulations, or regulatory policy statements. 98 Many of the states with some type of regulatory policy have utilized either the FSMB's Model Guideline or Policy in whole or in part. 99 The only two states that have yet to adopt any pain re- 100 While this Note does not formally endorse any specific guidelines or policy currently in existence, the Model Policy would be an excellent choice considering its wide range of endorsements and the ease at which the Board could adopt it.
B. The Michigan Guideline
The State of Michigan has taken an extensive approach to dealing with pain management and adopted Guidelines for the Use of Controlled Substances for the Treatment of Pain ("Guidelines") in late 2003. 101 In addition to the Guidelines, Michigan has adopted similar guidelines for nurses and pharmacists, maintains a website dedicated to pain management, sends a quarterly pain management newsletter to all licensed physicians, has distributed 70,000 copies of Dr. Scott Fishman's prescribing guide, and surveys licensed physicians on multiple areas including pain management practices.
102 Suffice it to say, pain management is a priority in Michigan. While Michigan is achieving many positive results in the area of pain management, its clear and unambiguous law is arguably the most important aspect of its pain management policies. Michigan's Guidelines are virtually identical to the Model Policy, including the Preamble and Definitions. 103 Further, Michigan's pain management policies and law received an A grade from the Wisconsin Pain and Policy Studies Group ("PPSG"). 104 The PPSG grades every state on the balance and clearness of its pain management laws, regulations, and other regulatory policies. 105 The grade is based on provisions that enhance pain management versus the provisions that hinder pain management, and a grade of A is only possible when a state's relevant policies completely eschew restrictive or ambiguous language. 106 108 In contrast, an Indiana Pharmacy regulation states, "[a] prescription for a controlled substance to be effective must be issued for a legitimate medical purpose in a reasonable quantity by an individual practitioner acting in the usual course of his professional practice." 109 The PPSG deemed this provision as potentially impeding pain management because it is ambiguous and sets an arbitrary standard for legitimate prescribing.
110
Because Michigan received thirty-seven positive provisions and zero negative provisions, the PPSG graded Michigan with an A, one of only five states to receive the grade.
111 Indiana received a C-plus grade because its policies and law contain only six positive and two restrictive or ambiguous provisions, including the one noted previously. 112 Michigan has abundant positive provisions and clearly promotes the safe and effective use of controlled substances for pain management, while Indiana has very few provisions, positive or negative, that relate to pain management and controlled substances.
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In addition to Michigan's positive report with the PPSG, they conducted a survey in 2009 for the first time on pain management practices in Michigan. 114 The survey included information on physician attitudes towards chronic pain treatment, physician pain management education, and reasons why physicians are reluctant to prescribe opioids. 115 The most interesting discovery was that when asked to define the greatest barrier to addressing pain, thirty-two percent of respondents answered that they were afraid their patients would become addicted to opioids, and only five percent stated it was fear of regulatory scrutiny. 116 Considering all of the literature and reports that cite fear of regulatory scrutiny as a primary barrier to proper pain treatment, it was the sixth of seven reasons stated as the cause of inadequate pain treatment in Michigan. 117 While Michigan respondents were not asked why they felt this way, one can reasonably conclude that the clarity of the law in Michigan has significantly lowered its physicians' con- cern over regulatory scrutiny. This seems particularly sensible because the current theory is that clear and unambiguous pain treatment regulations will reduce physician concern. 118 Thus, Michigan physicians feel (1) their patients will become addicted, (2) their patients fail to properly report pain, (3) lack of physician training and knowledge in pain management, (4) insufficient time to asses patient pain, and (5) lack of effective medicine are all greater barriers to adequate pain treatment than fear of investigation by authorities. 119 As such, where fear of regulatory scrutiny is a minor barrier in Michigan, the Michigan Board of Medicine ("Michigan Board") has taken steps to better educate its physicians by maintaining a website dedicated to pain management and sending a quarterly pain management newsletter to all licensed physicians. It has also distributed 70,000 copies of Dr. Scott Fishman's prescribing guide. Even though the Michigan Board has taken numerous steps to ensure that physicians have the tools to properly treat pain, its initial goal was to clarify the law on acceptable pain treatment. 120 That was done largely through Michigan's adoption of the Guidelines for the use of controlled substances for pain treatment in guideline form, thus reducing physician fear of regulatory scrutiny.
C. Indiana's Attempt to Promulgate a Rule for Using Controlled Substances in a Pain Treatment Setting
In 2006, the Board considered and came very close to adopting the Model Policy in almost its entirety. 121 On June 1, 2005, the Board filed a Notice of Intent to begin the promulgation process on rules concerning pain management and controlled substances. 122 In a letter to the Board, multiple Indiana physician organizations indicated that the reason for promulgation "was a reaction to requests made by physicians for clarification on the use of controlled substances for pain management. proposed rule that looked nearly identical to the Model Policy except it excluded the Preamble section, replacing every "should" with "shall" and essentially codifying in 844 IAC 5 a mandatory version of the Model Policy without the Preamble section. 125 The reason for the mandatory standard was the Advisory Division of the AG, which counsels the Board on legal matters. 126 The Advisory Division advised the Board that only a regulation should be promulgated to ensure enforceability. 127 For example, the Model Policy states, "The medical record should document the nature and intensity of the pain, current and past treatments for pain, underlying or coexisting diseases or conditions, the effect of the pain on physical and psychological function, and history of substance abuse. 
2012]
GUIDELINES FOR USING CONTROLLED SUBSTANCES FOR PAIN 715 mous vote. 134 However, after the Board sent the proposed rule to the AG for approval on September 8, 2005, the Board received multiple letters of concern from physician organizations, including the Indiana Chapter of the American College of Emergency Physicians, Indiana Academy of Family Physicians, Indiana Academy of Ophthalmology, Indiana Osteopathic Society, Indiana Psychiatric Society, Indiana Society of Anesthesiologists, and the ISMA. In each of the letters, the primary concern was the mandatory nature of the proposed rule established by the use of "shall" throughout. 135 As a result of the large medical outcry, the Board voted to recall the rule on September 23, 2005, 136 and it held an additional meeting on November 30, 2005 to discuss these concerns. 137 Although the meeting resulted in some consensus between Indiana medical organizations, the ISMA continued to oppose any standard in rule form and would only support a guideline form, arguing that a mandatory rule in this area would discourage and burden pain management rather than facilitate it. 138 Without the support of the ISMA and others, the Board decided to abandon the rule promulgation on February 23, 2006.
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D. How a Guideline Would Operate Under Indiana's Statutory Scheme
Considering the diversity of the fifty states in the United States, and the fact that policies and legislation regulating physician practice is primarily a state level function, every state is different in the way it investigates, prosecutes, and disciplines physician behavior. In Indiana, the Board may only discipline physicians who violate the Charging Statute.
140 Specifically concerning physician prescribing, the Catch All statute, requires some other basis to show the physician failed to keep abreast of current professional INDIANA HEALTH LAW REVIEW [Vol. 9:2 theory and practice. 141 A formally adopted guideline in this area would simply provide the basis for invoking the Catch All statute. For instance, the AG would charge the physician under the Catch All statute, citing the guideline and pointing to the specific deviation.
The most effective way for the Board to enforce and ensure affected physicians follow the guideline would be for the Board to codify a closely worded version of the Model Policy in 844 IAC 5, essentially completing the Board's attempt in 2006 with a few changes. Specifically, the Board should write the Model Policy into a rule under 844 IAC 5, leaving all the permissive characteristics, but where the Model Policy has a list of actions that physicians should adhere to, the Board should require that any deviation be documented in the record with a medical justification for the deviation. 142 The Board's rule under 844 IAC 5 would be identical to the Model Policy but would read, "any deviation from this section shall be documented in the medical record with medical justification for the deviation." This addition to the Model Policy would add enough teeth to properly enforce the guideline, while also giving physicians enough flexibility to meet each patient's need. Such a guideline promulgated in rule form would directly address the concern by the Advisory division and the medical community because although physicians would be required to document any deviation, the deviation would not automatically require discipline but allow for flexibility and consideration by the Board.
Under a rule promulgated in this fashion, the Board would be forced to consider the guideline under 844 IAC 5 because physicians would be required to document and thus highlight any deviation. The Board could then properly evaluate physician conduct, and in the event of a deviation from the policy, the Board would retain discretion to discipline or accept the deviation as appropriate where the circumstances warrant.
143 This would create a clear and unambiguous law concerning prescribing controlled substances for pain treatment, allow the AG to use an enforceable tool to prosecute inappropriate practices, and grant physicians a flexible standard to meet the varying needs of chronic pain patients. Michigan's Guideline is having in reducing fear of regulatory scrutiny, the Board should adopt a guideline for the use of controlled substances for the treatment of pain. Such a guideline will serve two direct and beneficial purposes by (1) providing the AG and the Board with a standard under which to evaluate physician prescribing practices, thus facilitating prosecution and discipline for those who use medicine as a pretext for diversion, and (2) clarifying the law and the Board's position in using controlled substances for pain treatment, which will help reduce physician fear of regulatory scrutiny and will facilitate the provision for proper treatment of patients with unremitting pain.
V. THE ROLE OF
A. A Guideline Will Clarify the Law and Create Case Evaluation Criteria
The Board should adopt a guideline based on a widely accepted standard of practice for physicians who prescribe controlled substances for pain treatment, such as the FSMB's Model Policy of 2004. Such a formally adopted or codified guideline will provide the Board with a foundational source for what has been determined to be proper standards of conduct. Rather than hearing arguments and relying on standards from other states, federal agencies, or private organizations, the Board would have its own resource to make such hearings more efficient and consistent. The current state of unclear and nonexistent laws or guidelines is unacceptable and detrimental to medical care. A guideline that represents the Board's expectations and establishes case evaluation criteria would define what unprofessional conduct looks like in a pain management setting. 144 This need is heightened by the fact that some standard of care concerning using controlled substances for pain treatment has been adopted in every state save for Indiana and Illinois.
The Indiana Medical Licensing Board Members Are Not Pain Management Specialists
One of the major reasons for formally adopting standards of practice for pain treatment or any specialized area of medicine is that Board members are not experts in every area of medicine. Moreover, currently no pain management specialists serve on the Board. 145 A study completed by Diane E. Hoffmann and Anita J. Tarzian revealed that numerous state medical board members believed their adoption of a guideline or policy was "a sig- 144 . See Stark, supra note 14, at 612-13; see also Leelyn, supra note 71, at 153 ("All states must adopt model guidelines, and medical board members, because of their vast power over health care practitioners, must internalize the model provisions and policies, and scrupulously apply them in evaluating physicians' prescription practices.").
145 
B. Clear Standards Put Physicians on Notice as to Proper Prescribing Practices
In addition to a guideline providing an evaluation and prosecution tool for the Board and the AG, a clear standard would communicate to physicians what is expected of them when it comes to prescribing opioids for pain treatment. The ability of physicians to know the Board's expectations serves two different needs: (1) so the physician may prescribe without fear of state investigation, and (2) so that when there is an investigation, the physician may adequately defend himself.
A Guideline Will Alleviate Fear of Regulatory Scrutiny
When physicians are aware that their state medical board has a clear and published standard of practice, their concerns about state investigation will likely recede because they will know what the state expects them to do. As noted in the 2009 Michigan survey, Michigan physicians report that they do not fear regulatory scrutiny, which is directly related, at least in part, to the fact that Michigan has clear policies and law on prescribing controlled substances for pain treatment. 178 The Model Policy was developed to "clarify the Board's position on pain control, particularly as related to the use of controlled substances, to alleviate physician uncertainty and to encourage better pain management."
179
Physicians who face investigation and charges will potentially pay a high price regardless of whether discipline is handed down, including financial costs, damage to reputation, loss of business, and other consequences. 180 Physicians are aware of the costs, and in an effort to avoid investigation and charges, many will alter their prescribing or avoid certain types of patients completely. 181 A guideline, especially when coupled with broad dissemination and communication activities from the Board, can alleviate the tension between physicians and the fear that their prescribing practices will lead to damaging scrutiny. If the guideline states that the medical chart should contain a medical history, patient examination, and a medical reason for the prescription, then the physician will know what the Board and the AG will be looking for in a chart should a patient complain. Further, if one of the provisions is not practical or possible for the specific patient, the physician will be aware of his deviation from the guideline and can document the reasons for such deviation. Without knowing the evaluation criteria used by the Board, physicians will continue to undertreat pain and refrain from subjecting themselves to unwarranted investigation.
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When physicians have a published guide from the Board, they can practice without fear because they will know the parameters of acceptable prescribing actions and will have a set of expectations with which they can comply. This is the core of barriers to adequate pain management, which the Board has the direct and sole ability to address and alleviate.
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A Clear Guide Will Enable Proper Defense
In addition to alleviating fear of regulatory scrutiny, a guideline will give physicians a clear standard they can use to defend their practices. Without a clear standard, physicians are unable to adequately defend themselves because there is no clear means under which to defend their actions. They are left to justify their prescribing behaviors under a standard of generally accepted practice, as is the AG. While the AG is in the same position from an evidentiary perspective, the common outcome is for the physician to settle.
On October 30, 2009, the AG filed a complaint against the license of Dr. Michael Punnett.
184 From March 2007 through November 2008, Dr. Punnett treated a patient for pain using different medication including Percocet, a schedule II controlled substance, Lortab, and Norco, both schedule III controlled substances. 185 Throughout the course of the treatment, the patient would ask for increased doses, decreased doses, early refills, and new medication because the medication had either been lost, stolen, or flushed by his wife. 186 On numerous occasions, Dr. Punnett rejected the patient's request for early refills or refused to prescribe anything more until the patient underwent another physical exam.
187 However, Dr. Punnett did prescribe different doses of medication at the patient's request several times-including when he claimed that he had lost his medication with his luggage, or that his wife had flushed them down the toilet . 188 In April 2008, Dr. Punnett noted in the patient's medical chart that the patient needed to be seen because of suspicious refill requests. Dr. Punnet examined the patient the next day, but there was nothing documented in the med- ical record as to what was discussed. 189 After being notified by the patient's wife that the patient was lying about losing his medication, Dr. Punnett conducted a follow-up examination and discovered that the patient was taking eight to ten Hydrocodone a day and had been admitted to a behavioral health program. 190 During the meeting, Dr. Punnett noted in the medical chart that opioids should not be given and the patient should potentially be discharged from the practice. 191 However, Dr. Punnett prescribed one last dose of Norco for the patient, and there was no mention in the medical chart as to a reason.
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The AG charged Dr. Punnett with multiple violations of prescribing to a known addict, failure to keep abreast of current theory or practice, and failure to take proper precaution to identify and address the patient's addiction. 193 Rather than take his chances with the Board, Dr. Punnett settled and simply received a Letter of Reprimand from the Board. 194 Had this case been presented before the Board, the outcome is speculative at best. Dr. Punnett did recognize that there were potential problems with the patient and brought him in for examination. However, he continued to prescribe for pain for reasons unknown. Pain management is a tricky and extremely subjective practice. 195 Maybe the patient really was in extreme pain, or maybe the patient, when he confessed he had a problem and was in a rehab program, truly needed the prescription in the medical judgment of Dr. Punnett. The point is, Dr. Punnett chose not to defend and place himself at the mercy of the Board. In the end, he settled for a potentially lesser discipline and walked away. Had there been some guidelines as to what the Board considered appropriate practice, Dr. Punnett would have been able to properly defend his practice and fight the charge before the Board. While a letter of reprimand does not technically restrict his ability to practice, it is public record, and other physicians may think twice before referring patients to him--in fearing that they might be implicated should something worse surface in the future.
The Punnett case illustrates the inability of physicians to adequately defend themselves and the propensity of a physician to settle rather than defend. This is an issue for the AG as well but presents a greater disadvantage to physicians because physicians stand to lose much more from an unfavorable outcome than does the AG. A guideline setting out evaluation 189 criteria would enable the physician to better evaluate his status under the guideline and thereby avoid an unwanted settlement because he could potentially present his case before the Board with the confidence and the knowledge that he followed the Board's expectations. Had there been a guideline, Dr. Punnett may have made a special notation as to his medical reasons for prescribing Norco to the patient after he discovered there were problems. Without a standard, many cases are too unclear, causing physicians to settle since at least then they have some control over the outcome.
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C. The Patients Will Receive Better Treatment
When physicians do not fear regulatory scrutiny and can properly defend complaints, patients with chronic pain ultimately are the beneficiaries. Patients will now have more confident doctors who can not only aggressively and effectively but also responsibly and safely treat their pain. Moreover, the general public benefits from more effective and consistent treatment by physicians prescribing controlled substances for pain treatment because good doctors are duly recognized, and those who contribute to prescription drug abuse are more easily identified and successfully disciplined.
VI. THE CASE AGAINST A GUIDELINE
In spite of all the benefits to be gained by adopting a guideline for the use of controlled substances for pain treatment, there are those who disapprove of the proposal for various reasons. However, despite the arguments, a guideline with an enforceability mechanism is in the best interest for all concerned.
A. There is No Enforceability With a Guideline
The argument against a guideline as advocated by the AG's Advisory Division is that a guideline lacks teeth or enforceability and ultimately will be useless, or even more problematic and confusing to implement. Only statutes and regulations which are promulgated by the Board can be enforced, and a guideline would give a false sense of enforceability, ultimately meaning nothing when the Board actually contemplates discipline for physician conduct. It is important to note that the Board would not discipline under the guideline, but rather, it would discipline under the Catch All statute citing the guideline as evidence of the physicians' inappropriate 196. Hoffmann & Tarzian, supra note 67, at 36 (" [Standards] serve to reassure physicians that they will not be disciplined for overprescribing opioids to patients with chronic pain if they conform to standards of practice and state pain policies.").
